Intuitive Surgical Inc. stock underperforms Thursday when compared to competitors
Intuitive Surgical Inc. (ISRG) shares fell by 5.84% on Thursday, closing at $374.48, underperforming the broader market as the S&P 500 Index and Dow Jones Industrial Average also experienced declines. This drop broke a two-day winning streak for the stock.
Intuitive Surgical slides as investors continue to digest cautious outlook
Intuitive Surgical (ISRG) stock slid by 4.9% today, likely due to continued investor reaction to its July earnings reset. Despite strong second-quarter revenue of $2.89 billion and a 16% rise in worldwide procedures, the company maintained a cautious full-year outlook for da Vinci procedure growth and anticipated tariff-related margin pressure. The drop is not attributed to new August press releases, suggesting ongoing valuation adjustments post-earnings.
Intuitive Surgical Inc Stock (ISRG) Moved Down by 4.89% on Aug 20: What Signal Does It Send?
Intuitive Surgical Inc (ISRG) stock fell by 4.89% due to concerns over increasing competition in the robotic-assisted surgery market, regulatory clearances for rival systems, and a cautious full-year guidance despite strong operational metrics. Wall Street analysts also revised price targets downward, reflecting hospital capital expenditure caution and broader market anxieties. Technical indicators show a mix of buy, neutral, and sell signals, with low media attention and generally bullish market sentiment.
GSA Capital Partners LLP Raises Stake in Medtronic PLC $MDT
GSA Capital Partners LLP significantly increased its stake in Medtronic PLC (NYSE:MDT) by 1,112.5% during the second quarter, bringing its total holdings to 68,541 shares valued at $5.36 million. Medtronic recently exceeded quarterly earnings and revenue expectations, and raised its quarterly dividend to $0.72 per share, offering a 3.1% yield. Analysts generally maintain a "Moderate Buy" rating with an average price target of $98.83, despite some risks such as potential legal action and continued insider selling.
Colrain Capital LLC Has $10.45 Million Position in Medtronic PLC $MDT
Colrain Capital LLC increased its stake in Medtronic PLC by 26.1% in the second quarter, now holding 132,354 shares valued at $10.45 million. Institutional investors collectively own 82.06% of Medtronic, which has a consensus "Moderate Buy" rating. The company recently exceeded earnings expectations, raised its dividend, but faces some analyst target reductions and insider selling.
Intuitive Surgical (ISRG), What Is Behind The Fresh Attention?
Intuitive Surgical (ISRG) is garnering renewed interest following announcements of a new manufacturing facility in Malaysia, My Intuitive+ renewals, and updates to its da Vinci 5 platform. Despite a recent 30-day stock rebound of 12.61%, the year-to-date share price has declined by 29.23%. The article discusses differing valuation perspectives, with a narrative suggesting the stock is 36.9% undervalued at $630.48, contrasting with market multiples indicating a premium valuation with a P/E of 44.8x.
Mark Brosius Sells 77 Shares of Intuitive Surgical (NASDAQ:ISRG) Stock
Mark Brosius, EVP at Intuitive Surgical (NASDAQ:ISRG), sold 77 shares of the company's stock on August 17th at an average price of $390.67, totaling $30,081.59. This transaction, executed under a Rule 10b5-1 plan, reduced his direct ownership by 6.08% to 1,189 shares. The company recently reported strong quarterly results, exceeding expectations with $2.80 EPS and $2.89 billion in revenue, leading analysts to maintain a "Moderate Buy" rating with an average price target of $508.68.
Intuitive Surgical (NASDAQ: ISRG) exec’s plan sells 231 shares
Mark Brosius, EVP & Chief Manufacturing and Supply Chain at Intuitive Surgical (NASDAQ: ISRG), sold 231 shares of common stock over three days in August 2026. These sales, totaling approximately $91,000, were executed under a pre-arranged Rule 10b5-1 trading plan. After these transactions, Brosius directly holds 1,035 shares of common stock.
Tenet Healthcare (NYSE:THC) Stock Price
Tenet Healthcare (NYSE:THC) is currently trading at US$268.52, with a fair value estimate of US$250, indicating it is overvalued by 7.4%. Analyst narratives provide varying perspectives, with some highlighting growth drivers like behavioral care and outpatient trends, while others caution about M&A risks and Medicaid reliance. Recent insider transactions show net selling activity.
Intuitive Surgical Inc. stock underperforms Wednesday when compared to competitors despite daily gains
Intuitive Surgical Inc. (ISRG) shares rose 1.67% on Wednesday, closing at $397.72, despite the company's stock underperforming relative to its competitors. The daily gain occurred on an overall positive trading day for the market, with the S&P 500 Index and Dow Jones Industrial Average also seeing increases. This marked the second consecutive day of gains for Intuitive Surgical Inc.
Intuitive Surgical Expands Manufacturing Footprint in Asia Pacific
Intuitive Surgical (ISRG) is expanding its manufacturing presence in Asia Pacific with a new 316,000-square-foot facility in Penang, Malaysia. This move aims to meet the rising demand for robotic-assisted surgery in the region and strengthen the company's global manufacturing network. The facility, expected to begin operations in 2028, will create approximately 1,200 jobs and produce surgical instruments and electromechanical devices for its da Vinci surgical systems.
Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst
Abbott Laboratories' Medical Devices segment is a primary growth driver, fueled by advancements in electrophysiology, increasing adoption of cardiovascular technologies, and the long-term potential of continuous glucose monitoring (CGM). The company is launching new products like the Volt PFA catheter and Libre Duo for glucose and ketone monitoring, and has a strong cardiovascular pipeline extending to 2029 and beyond. Despite this, Abbott's stock has underperformed the industry and currently trades at a higher valuation.
Here's How Abbott's Medical Devices Arm Acts as a Growth Catalyst
Abbott Laboratories' Medical Devices segment is a key growth driver, propelled by advancements in electrophysiology, widespread adoption of cardiovascular technologies, and the significant long-term potential of continuous glucose monitoring (CGM). The company is launching next-generation products like the Volt PFA catheter and Libre Duo, while also developing a robust cardiovascular pipeline extending into 2029 and beyond. Despite these growth catalysts, ABT shares have declined in the past year, and the stock trades at a higher Price-to-Sales multiple compared to the industry median.
Trust Co. of Vermont Invests $1.68 Million in Intuitive Surgical, Inc. $ISRG
Trust Co. of Vermont recently invested $1.68 million in Intuitive Surgical, Inc. (NASDAQ:ISRG) by purchasing 4,224 shares during the second quarter. This move is part of broader institutional interest, with other firms also adjusting their stakes in the medical equipment provider. Despite some insider selling, analysts generally maintain a "Moderate Buy" rating for Intuitive Surgical, forecasting growth for the company.
Medtronic PLC $MDT Position Reduced by Hedeker Wealth LLC
Hedeker Wealth LLC reduced its stake in Medtronic PLC (NYSE:MDT) by 36.6% in the second quarter, selling 17,444 shares and retaining 30,282 shares valued at $2,369,000. Other institutional investors showed mixed activity, with some increasing and others reducing their positions in MDT. Insider activity includes an EVP selling over 4,000 shares, and analysts have issued a "Moderate Buy" consensus rating with a target price of $98.83.
1,681,360 Shares in Zimmer Biomet Holdings, Inc. $ZBH Purchased by Equity Investment Corp
Equity Investment Corp recently acquired 1,681,360 shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) valued at approximately $144.75 million, making it their 11th largest holding. Other institutional investors also adjusted their positions in the medical equipment provider, which saw its stock open at $99.31 with a market cap of $18.94 billion. The company recently declared a quarterly dividend of $0.24 and analysts have a "Hold" consensus rating with an average target price of $104.42.
Intuitive Surgical stock steadies as da Vinci 5 cardiac clearance reshapes growth story
Intuitive Surgical (ISRG) stock has stabilized despite a 30% year-to-date decline in 2026, driven by strong procedure growth and the recent da Vinci 5 cardiac clearance. The company reported 16% worldwide procedure growth and 19% revenue growth in Q2 2026, but tempered full-year guidance and competition have compressed its valuation. New regulatory clearances for cardiac procedures using the da Vinci 5 system present a significant long-term growth opportunity, with potential for a ninefold expansion in cardiac procedure volumes.
BlackRock Inc. Purchases Shares of 24,592,166 Becton, Dickinson and Company $BDX
BlackRock Inc. recently acquired a new stake of 24,592,166 shares in Becton, Dickinson and Company (NYSE:BDX), valued at approximately $3.72 billion, representing about 8.93% of the company. The article also details recent analyst ratings, with a consensus "Hold" rating and an average price target of $185.67, alongside insider selling activity and the company's latest financial performance and dividend announcement. Becton, Dickinson and Company reported strong earnings for the last quarter, beating consensus estimates, and announced a quarterly dividend of $1.05 per share.
Intuitive Surgical stock stabilizes after sharp 2026 pullback as new cardiac use expands da Vinci 5
Intuitive Surgical's stock has seen a sharp decline of over 30% in 2026, reaching the high-$390 range despite continued double-digit procedure growth for its da Vinci systems. This valuation reset is attributed to competitive pressures and a sector-wide sell-off. However, recent FDA clearance for cardiac procedures on the new da Vinci 5 platform presents a significant opportunity, potentially expanding the addressable market by a factor of nine, and analysts still project double-digit earnings growth for the company.
Is ISRG's Software Strategy Becoming as Important as Its Robots?
Intuitive Surgical (ISRG) is increasingly relying on its software strategy to enhance the value of its da Vinci 5 robotic platform, extending its competitive moat beyond just hardware. The company is implementing numerous software updates and integrated offerings like My Intuitive+ to improve usability, efficiency, and clinical capabilities, fostering customer loyalty and supporting its recurring-revenue model. This approach is also being mirrored by competitors like Stryker and Zimmer Biomet, who are embedding digital capabilities into their robotic ecosystems to differentiate their solutions and strengthen market stickiness.
Qsemble Capital Management LP Has $2.57 Million Position in Medtronic PLC $MDT
Qsemble Capital Management LP significantly increased its stake in Medtronic PLC, raising its position by 507.7% to 32,835 shares valued at $2.57 million. Other institutional investors also adjusted their holdings in Medtronic, which recently reported strong earnings, increased its dividend, and received mixed but generally positive analyst ratings. An executive insider also sold a portion of their shares.
Medtronic PLC $MDT Holdings Increased by Willis Investment Counsel
Willis Investment Counsel increased its stake in Medtronic PLC (NYSE:MDT) by 5.7% during the second quarter, bringing its total holdings to 414,539 shares valued at $32.43 million. This makes Medtronic the 22nd largest holding for the firm, comprising 1.5% of its investment portfolio. Other institutional investors also adjusted their positions in Medtronic, which currently has a consensus rating of "Moderate Buy" and a target price of $98.83 from analysts.
Flputnam Investment Management Co. Takes $1.52 Million Position in Becton, Dickinson and Company $BDX
Flputnam Investment Management Co. recently acquired a $1.52 million stake in Becton, Dickinson and Company (BDX) during the second quarter, purchasing 10,080 shares. Institutional investors collectively own 86.97% of the company. Becton, Dickinson and Company exceeded analyst expectations with its recent earnings, reporting $4.98 billion in revenue and $3.23 EPS, while also maintaining its fiscal 2026 EPS guidance.
Intuitive Surgical Inc. stock underperforms Monday when compared to competitors
Intuitive Surgical Inc. (ISRG) stock fell 1.06% on Monday, closing at $390.33, underperforming the broader market. This marks the second consecutive day of losses for the company, as the S&P 500 Index and Dow Jones Industrial Average also experienced declines.
CVS Health Corp Stock (CVS) Moved Down by 3.46% on Aug 17: A Full Analysis
CVS Health Corp's stock (CVS) dropped by 3.46% on August 17, driven by investor caution regarding medical cost trends and structural changes within its Caremark pharmacy benefit management unit, despite the company raising its full-year earnings guidance. Technical indicators show negative momentum for the stock, with a MACD value of -2.245, while fundamental analysis highlights its significant revenue within the Healthcare Services & Equipment industry. Investors are scrutinizing the company's ability to sustain margins amid regulatory scrutiny, elevated utilization rates, and long-term debt.
Johnson & Johnson wins FDA clearance for new robotic bronchoscopy software
Johnson & Johnson MedTech has launched Monarch Quest 3, the latest software iteration for its Monarch robotically assisted bronchoscopy platform, following FDA 510(k) clearance. This update enhances navigation, control, and targeting assistance for lung biopsies through features like a 3D compass overlay and AI-powered nodule segmentation. The company emphasizes its commitment to advancing the platform to improve outcomes for lung cancer patients amidst increasing competition in the robotic bronchoscopy space.
J&J’s Monarch robot wins FDA nod for AI features
Johnson & Johnson's Monarch bronchoscopy robot has received FDA clearance for a software update that integrates artificial intelligence features. These enhancements aim to improve pre-procedure planning, navigation, and targeting during lung cancer diagnosis procedures. The Monarch system, which competes with Intuitive's Ion and Noah Medical's Galaxy, now offers more accurate nodule boundary generation and improved visual orientation for physicians.
Costco Is Up 11% in 2026. Here’s Where the Stock Could Go
Costco's stock is up 11% year-to-date in 2026, but its growth rate is stabilizing after strong comparisons in 2025. While July net sales increased by 10.7%, the acceleration has slowed, and the stock trades at a high 48 times earnings. Analysts project a mid-case target of $1,415, implying a 47% total return over four years, driven by warehouse expansion and membership fees, with the primary risk being the high multiple.
Intuitive Surgical Fell 30% in 2026 as a Rival Arrived. Here’s Where the Stock Could Go
Intuitive Surgical (ISRG) stock fell 30% in 2026, primarily due to the FDA clearance of Johnson & Johnson’s Ottava robot, introducing a significant rival in soft-tissue surgery. Despite the competitive threat, ISRG reported a 19% revenue increase, but management's decision not to raise full-year guidance after a strong Q2 contributed to the stock's decline. The article suggests that the key to future performance lies in U.S. da Vinci procedure growth and how quickly the new competitor gains market share, urging investors to watch Q3 results.
Medtronic Bets Its Surgical AI Future On Compute, Not Just The Hugo Robot
Medtronic is focusing its surgical AI strategy on advanced computing rather than solely on its Hugo robot. This approach suggests a broader vision for AI integration in surgical procedures, moving beyond just robotic platforms. The article implies that the company believes the future of surgical AI lies in the underlying computational power and data processing capabilities.
Intuitive Adds New Manufacturing Facility in Malaysia
Intuitive has announced a new 316,000-square-foot manufacturing facility in Penang, Malaysia, which is expected to open in 2028 and create 1,200 skilled jobs by 2032. This expansion aims to increase global manufacturing capacity for da Vinci surgical instruments and electromechanical devices, addressing the growing demand in the Asia-Pacific region. The investment highlights Intuitive's long-term commitment to the area and strengthens Penang's position as a MedTech hub.
How Stronger 2026 Sales and Earnings Will Impact UFP Technologies (UFPT) Investors
UFP Technologies (UFPT) reported strong Q2 and H1 2026 results with increased sales and net income, reinforcing its investment narrative as a specialized supplier to medical device companies. The company's future outlook projects significant revenue and earnings growth by 2029, leading to a fair value estimate that suggests an upside to its current price. However, investors are cautioned about the concentration risk due to dependence on a few large customers.
Hikari Power Ltd Acquires New Stake in Intuitive Surgical, Inc. $ISRG
Hikari Power Ltd has acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, purchasing 14,130 shares valued at approximately $5.6 million. This investment represents about 0.7% of Hikari Power Ltd's portfolio, making Intuitive Surgical its 15th largest position. The medical equipment provider recently exceeded quarterly expectations with $2.80 in EPS and $2.89 billion in revenue, prompting analysts to maintain a "Moderate Buy" consensus with an average price target of $508.68.
Plato Investment Management Ltd Makes New Investment in Intuitive Surgical, Inc. $ISRG
Plato Investment Management Ltd acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the second quarter, purchasing 10,914 shares valued at approximately $4.315 million. This investment comes as institutional investors collectively own 83.64% of the company, which recently reported strong quarterly earnings exceeding analyst estimates. Despite positive earnings, the stock has experienced a sell-off, and several analysts have recently adjusted their price targets or ratings.
Oppenheimer & Co. Inc. Reduces Stock Holdings in Medtronic PLC $MDT
Oppenheimer & Co. Inc. decreased its stake in Medtronic PLC by 7.1% during the second quarter, selling 13,947 shares to hold a total of 183,078 shares valued at $14.32 million. Despite this reduction, other institutional investors have increased their holdings in Medtronic. The company recently announced a dividend increase to $0.72 per share, and analysts have a "Moderate Buy" rating with an average target price of $98.83.
Massachusetts Financial Services Co. MA Has $1.55 Billion Stock Holdings in Medtronic PLC $MDT
Massachusetts Financial Services Co. MA reduced its stake in Medtronic PLC by 7.3% in the second quarter, now holding 19.87 million shares valued at $1.55 billion. Medtronic reported strong quarterly earnings, beating analyst estimates, and increased its quarterly dividend. The company also received several analyst upgrades, with a consensus target price of $98.83.
Daymark Wealth Partners LLC Sells 35,341 Shares of Medtronic PLC $MDT
Daymark Wealth Partners LLC significantly reduced its stake in Medtronic PLC (NYSE:MDT) by 66.1% in the second quarter, selling 35,341 shares and holding 18,109 shares valued at $1.417 million. Despite this, other major institutional investors like Vanguard Group Inc., State Street Corp, and JPMorgan Chase & Co. increased their positions in Medtronic. The article also notes an insider sale by EVP Harry Skip Kiil and summarizes various analyst ratings and financial performance data for Medtronic, including a recent dividend increase.
297,894 Shares in Zimmer Biomet Holdings, Inc. $ZBH Bought by Alberta Investment Management Corp
Alberta Investment Management Corp recently purchased 297,894 shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) valued at approximately $25.65 million, establishing a new position in the medical equipment provider. Other institutional investors also adjusted their holdings in ZBH, which currently has a "Hold" rating from analysts with an average target price of $104.42. The article also notes recent insider selling and provides financial performance metrics and dividend information for Zimmer Biomet.
Intuitive Expands Manufacturing Footprint in Asia Pacific with New Facility in Penang, Malaysia
Intuitive, a leader in robotic-assisted surgery, is expanding its manufacturing operations in Asia Pacific with a new 316,000-square-foot facility in Penang, Malaysia. This investment, expected to begin operations in 2028 and create 1,200 jobs by 2032, will support the increasing demand for its da Vinci surgical systems and related instruments in the region. The move highlights Intuitive's long-term commitment to Asia Pacific and reinforces Penang's role as a growing MedTech hub.
GSA Capital Partners LLP Invests $2.50 Million in Matrix Service Company $MTRX
GSA Capital Partners LLP has invested approximately $2.50 million in Matrix Service Company by acquiring 182,277 shares. This new stake represents about 0.65% of Matrix Service, which has a significant institutional ownership of 78.38%. Analysts currently rate Matrix Service as a "Moderate Buy" with a consensus price target of $20.50.
S&CO Inc. Acquires New Holdings in Intuitive Surgical, Inc. $ISRG
S&CO Inc. has acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by purchasing 5,121 shares valued at approximately $2.04 million in the second quarter. This move comes as Intuitive Surgical reported strong quarterly results, exceeding analyst estimates with earnings of $2.80 per share and revenue of $2.89 billion, marking an 18.4% year-over-year increase. Despite some insider selling, analysts maintain a "Moderate Buy" consensus with an average price target significantly above the current stock price.
S&CO Inc. Acquires Shares of 59,425 Adams Natural Resources Fund, Inc. $PEO
S&CO Inc. recently acquired 59,425 shares of Adams Natural Resources Fund (NYSE: PEO), valued at approximately $2.74 million, increasing its stake to 0.22% of the fund's outstanding shares. Other institutional investors also boosted their holdings, bringing total institutional ownership to 33.54%. The fund's shares opened at $27.80, and it increased its quarterly dividend to $0.54 per share, resulting in a 7.8% dividend yield.
Oppenheimer Asset Management Inc. Purchases New Stake in Privia Health Group, Inc. $PRVA
Oppenheimer Asset Management Inc. recently acquired 226,999 shares of Privia Health Group, Inc. (NASDAQ:PRVA) for approximately $5.84 million, increasing institutional ownership to 94.48%. Despite some insider selling, analysts maintain a "Moderate Buy" consensus with an average price target of $31.00. The stock opened at $22.00, below its 50-day moving average, with a market capitalization of $2.81 billion.
Langley Wealth Management LLC Invests $126,000 in Coca-Cola Consolidated, Inc. $COKE
Langley Wealth Management LLC recently acquired 16,066 shares of Coca-Cola Consolidated, Inc. (COKE) for approximately $126,000, making it 0.9% of their portfolio. Institutional investors hold 48.24% of the company, which reported strong quarterly earnings of $2.83 per share on $2.05 billion in revenue. Despite a recent downgrade to "Hold," analyst sentiment for COKE stock remains generally positive with an average "Buy" rating.
Sandro Wealth Management LLC Acquires Shares of 9,476 American Water Works Company, Inc. $AWK
Sandro Wealth Management LLC has acquired a new stake of 9,476 shares in American Water Works Company, Inc. (NYSE:AWK), valued at approximately $1.25 million. This comes as American Water Works exceeded quarterly expectations with $1.61 EPS and $1.35 billion in revenue, and has guided for fiscal 2026 EPS between $6.02 and $6.12. Analysts currently maintain a consensus "Hold" rating for the stock with an average price target of $138.78.
27,689 Shares in United Natural Foods, Inc. $UNFI Acquired by Private Advisory Group LLC
Private Advisory Group LLC recently acquired 27,689 shares of United Natural Foods, Inc. (UNFI) worth approximately $1.27 million, making them a new institutional investor in the company. Despite this acquisition and other institutional holdings, Wall Street analysts maintain a cautious "Hold" rating with an average price target of $47.86, following UNFI's recent earnings miss and revenue decline. The company is a leading distributor of natural, organic, and specialty foods in North America, with a market capitalization of $2.93 billion.
S&CO Inc. Buys Shares of 10,865 EOG Resources, Inc. $EOG
S&CO Inc. recently purchased 10,865 shares of EOG Resources, Inc. valued at approximately $1.4 million during the second quarter. This acquisition is part of broader institutional investment, with hedge funds and institutional investors collectively owning 89.91% of EOG's stock. Analysts currently hold a "Hold" rating for EOG, which has an average price target of $156.21, and the company recently surpassed its earnings and revenue forecasts while announcing a quarterly dividend.
Maridea Wealth Management LLC Makes New $2.75 Million Investment in HealthEquity, Inc. $HQY
Maridea Wealth Management LLC has made a new $2.75 million investment in HealthEquity, Inc., acquiring 30,479 shares during the second quarter. HealthEquity recently reported strong quarterly earnings of $1.24 per share, surpassing estimates, and saw its revenue increase by 7.2% year over year. Analysts maintain a "Moderate Buy" rating for the stock, with an average price target of $110.93.
Maridea Wealth Management LLC Makes New Investment in UFP Technologies, Inc. $UFPT
Maridea Wealth Management LLC recently acquired a new stake in UFP Technologies, Inc. (NASDAQ:UFPT) by purchasing 7,901 shares valued at approximately $2.1 million. This investment highlights continued institutional interest in UFP Technologies, which has also seen other firms adjust their holdings. The company has demonstrated strong financial performance, exceeding quarterly earnings and revenue estimates, though insider selling has also occurred.
S&CO Inc. Makes New $1.24 Million Investment in Liberty Latin America Ltd. $LILA
S&CO Inc. has invested $1.24 million in Liberty Latin America Ltd. (NASDAQ:LILA), acquiring 157,758 shares, making up 0.08% of its portfolio. This comes as institutional ownership in Liberty Latin America reached 18.48%, with shares trading near their 52-week high at $8.62. Analysts currently rate the stock as a "Hold" with an average price target of $10.00, despite the company reporting a quarterly loss of $0.13 per share.
